Osaka, Japan

Yukie Akagi

This inventor holds 1 USPTO granted patent. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukie Akagi. Retrieved from https://idiyas.com/inventor/yukie-akagi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yukie Akagi: Innovator in Ophthalmic Compositions

Introduction

Yukie Akagi is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of ophthalmology through her innovative research and development of ophthalmic compositions. Her work focuses on creating solutions that minimize side effects while effectively treating eye disorders.

Latest Patents

Yukie Akagi holds a patent for ophthalmic compositions that utilize an adrenergic β receptor agonist with high selectivity toward adrenergic β receptors. This innovative formulation is designed to have negligible side effects on the heart, making it a safer option for patients. The compositions are intended for use as preventives or therapeutics for xerophthalmic disorder and keratoconjunctival disorder. She has 1 patent to her name.

Career Highlights

Yukie Akagi is associated with Rohto Pharmaceutical Co., Ltd., a company known for its commitment to developing effective healthcare solutions. Her work at Rohto has allowed her to focus on advancing ophthalmic treatments that benefit patients worldwide.

Collaborations

Yukie collaborates with notable colleagues, including Yoichi Honma and Ichiro Hirotsu. Their combined expertise contributes to the innovative research and development efforts at Rohto Pharmaceutical Co., Ltd.

Conclusion

Yukie Akagi's contributions to ophthalmic compositions highlight her dedication to improving patient care through innovative solutions. Her work continues to pave the way for advancements in the treatment of eye disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…